Government Funding for the Development of Enzalutamide
This cross-sectional study assesses the various patents and US government grants that were critical to the publicly funded development of the cancer drug enzalutamide.
Authors
- Emily H. Jung (ORCID: https://orcid.org/0000-0001-8496-7806)
- Helen Mooney
- Bishal Gyawali (ORCID: https://orcid.org/0000-0002-8315-1925)
- Jerry Avorn (ORCID: https://orcid.org/0000-0003-0255-2346)
- Aaron Seth Kesselheim (ORCID: https://orcid.org/0000-0002-8867-2666)
Institutions
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Queen's University (CA)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2024-12-19
- DOI
- https://doi.org/10.1001/jamaoncol.2024.5661
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00